The levels of soluble versus insoluble brain aβ distinguish Alzheimer's disease from normal and pathologic aging

Experimental Neurology

Volumn 158, Issue 2, 1999, Pages 328-337

  Wang, Jun ^a   Dickson, Dennis W ^b   Trojanowski, John Q ^a   Lee, Virginia M Y ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Amyloid plaques; Amyloidosis; A peptide; Heterogeneity.

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BRAIN EXTRACT; MONOCLONAL ANTIBODY;

ADULT; AGED; AGING; ALZHEIMER DISEASE; AMYLOIDOSIS; ARTICLE; BRAIN; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SENILE PLAQUE; SOLUBILITY;

EID: 0032837741     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1999.7085     Document Type: Article

References (36)

1. Cook D. G., Forman M. S., Chyung A. S. C., Doms R. W., Lee V. M.-Y. Biosynthesis of APP and Aβ: Multiple pathways for the generation of intracellular Aβ Hass C. Molecular Biology of Alzheimer's Disease. 1998.
2. Ginsberg S. D., Schmidt M. L., Crino P. B., Eberwine J. H., Lee V. M.-Y., Trojanowski J. Q. Molecular pathology of Alzheimer's disease and related disorders. Morrison A., Peters A. Cerebral Cortex. 1998.
3. Lansbury P. T. Structural neurology: Are seeds at the root of neuronal degeneration. Neuron. 19:1997;1151-1154.
4. Saido T. C., Yokota M., Tani E., Kawashima S. Post-secretory catabolism of β-amyloid in brain. Alzheimer's Disease: Biology, Diagnosis and Therapeutics. 1997;Wiley, New York. p. 337-346.
5. Selkoe D. J. Cellular and molecular biology of the β amyloid precursor protein and Alzheimer's disease. Prusiner S. B., DiMauro S., Barchi R. L. The Molecular and Genetic Basis of Neurological Disease. 1997;601-612 Butterworth, Boston.
6. Goedert M., Trojanowski J. Q., Lee V. M.-Y. The neurofibrillary pathology of Alzheimer's disease. Prusiner S. B., DiMauro S., Barchi R. L. The Molecular and Genetic Basis of Neurological Disease. 1997;613-628 Butterworth, Boston.
7. Fukumoto H., Asami-Odaka A., Suzuki N., Shimada H., Ihara Y., Iwatsubo T. Amyloid β protein deposition in normal aging has the same characteristics as that in Alzheimer's disease. Predominance of Aβ42(43) and association of Aβ40 with cored plaques. Am. J. Pathol. 148:1996;259-265.
8. Iwatsubo T., Mann D. M. A., Odaka A., Suzuki N., Ihara Y. Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in Down syndrome. Ann. Neurol. 37:1995;294-299.
9. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., Ihara Y. Visualization of Aβ42(43)-positive and Aβ40-positive senile plaques with end-specific Aβ-monoclonal antibodies: Evidence that an initially deposited Aβ species is Aβ1-42(43). Neuron. 13:1994;45-53.
10. Iwatsubo T., Saido T. C., Mann D. M. A., Lee V. M.-Y., Trojanowski J. Q. Full-length Aβ(1-42(43)) as well as amino-terminally modified and truncated Aβ42(43) deposit in diffuse plaques. Am. J. Pathol. 49:1996;1823-1830.
11. Lemere C. A., Blusztajn J. K., Yamaguchi H., Wisniewski T., Saido T. C., Selkoe D. J. Sequence of deposition of heterogeneous amyloid Aβ peptides and APO E in Down syndrome: Implications for initial events in amyloid plaque formation. Neurobiol. Dis. 3:1996;16-32.
12. Saido T. C., Iwatsubo T., Mann D. M. A., Shimada H., Ihara Y., Kawashima S. Dominant and differential deposition of distinct β-amyloid peptide species, Aβn3(pE), in senile plaques. Neuron. 14:1995;1-20.
13. Saido T. C., Yamao-Harigaya W., Iwatsubo T., Kawashima S. Amino- and carboxyl-terminal heterogeneity of β-amyloid peptides deposited in human brain. Neurosci. Lett. 215:1996;173-176.
14. Arai H., Lee V. M.-Y., Otvos L. Jr., Greenberg B. D., Lowery D. E., Sharma S. K., Schmidt M. L., Trojanowski J. Q. Defined neurofilament, tau and beta-amyloid protein epitopes distinguish Alzheimer from non-Alzheimer senile plaques. Proc. Natl. Acad. Sci. USA. 87:1990;2249-2253.
15. Arriagada P. A., Growdon J. H., Hedley-White E. T., Hyman B. T. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology. 42:1992;631-639.
16. Cummings B. J., Pike C. J., Shankle R., Cotman C. W. β-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease. Neurobiol. Aging. 17:1996;921-933.
17. Dickson D. W. The pathogenesis of senile plaques. J. Neuropathol. Exp. Neurol. 56:1997;321-339.
18. Dickson D. W., Crystal H. A., Mattiace L. A., Masur D. M., Blau A., Davies P., Yen S.-H., Aronson M. K. Identification of normal and pathologic aging in prospectively studied nondemented elderly humans. Neurobiol. Aging. 13:1991;179-189.
19. Schmidt M. L., DiDario A. G., Otvos L. Jr., Hoshi N., Kant A., Lee V. M.-Y., Trojanowski J. Q. Plaque-associated neuronal proteins: A recurrent motif in neuritic amyloid deposits throughout diverse cortical areas of the Alzheimer's disease brain. Exp. Neurol. 130:1994;311-322.
20. Skovronsky D. M., Doms R. W., Lee V. M.-Y. Detection of a novel, intraneuronal pool of insoluble Aβ that accumulates with age in culture. J. Cell Biol. 141:1998;1031-1039.
21. 42 are generated intracellularly in cultured human neurons and their secretion increases with maturation. J. Biol. Chem. 271:1996;8966-8970.
22. Schmidt M. L., Lee V. M.-Y., Saido T., Perl D., Schuck T., Iwatsubo T., Trojanowski J. Q. Amyloid plaques in Guam amyotrophic lateral sclerosis/Parkinsonism-dementia complex contain species of Aβ similar to those found in the amyloid plaques of Alzheimer's disease and pathological aging. Acta Neuropathol. 95:1998;117-122.
23. Tekirian T. L., Saido T. C., Markesbery W. R., Russell M. J., Werkstein D. R., Patel E., Geddes J. W. N-terminal heterogeneity of parenchymal and cerebrovascular Aβ deposits. J. Neuropathol. Exp. Neurol. 57:1998;76-94.
24. Shinkai Y., Yoshimura M., Morishima-Kawashima M., Ito Y., Shimada H., Yanagisawa K., Ihara Y. Amyloid β-protein deposition in the leptomeninges and cerebral cortex. Ann. Neurol. 42:1997;899-908.
25. Naslund J., Schierhorn A., Hellman U., Lannfelt L., Roses A. D., Tjeruberg L. O., Silberring J., Gandy S. E., Winblad B., Greengard P. Relative abundance of Alzheimer Aβ amyloid peptide variants in Alzheimer's disease and normal aging. Proc. Natl. Acad. Sci. USA. 91:1994;8378-8382.
26. Suzuki N., Cheung T. T., Cai X. D., Odaka A., Otvos L. Jr., Eckman C., Golde T. E., Younkin S. G. An increased percentage of long amyloid β-protein secreted by familial amyloid β-protein precursor (βAPP717) mutants. Science. 264:1994;1336-1340.
27. PHF proteins display the same biochemical properties as normal τ J. Biol. Chem. 267:1992;564-569.
28. Hoffman R., Lee V. M.-Y., Leight S., Varga I., Otvos L. Jr. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites. Biochemistry. 36:1997;8114-8124.
29. Schmidt M. L., DiDario A. G., Lee V. M.-Y., Trojanowski J. Q. An extensive network of PHFτ-rich dystrophic neurites permeates neocortex and nearly all neuritic and diffuse amyloid plaques in Alzheimer disease. FEBS Lett. 344:1994;69-73.
30. Shin R.-W., Ogino K., Kondo A., Saido T., Trojanowski J. Q., Kitamoto T., Tateishi J. Amyloid β-protein (Aβ) 1-40 but not Aβ1-42 contributes to the experimental formation of Alzheimer's disease amyloid fibrils in rat brain. J. Neurosci. 17:1997;8187-8193.
31. Wertkin A. M., Turner R. S., Pleasure S. J., Golde T. E., Younkin S. G., Trojanowski J. Q., Lee V. M.-Y. Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular β-amyloid or A4 peptides. Proc. Natl. Acad. Sci. USA. 90:1993;9513-9517.
32. Gravina S. A., Ho L., Eckman C. B., Long K. E., Otvos L. Jr., Younkin L. H., Suzuki N., Younkin S. G. Amyloid βprotein (Aβ) in Alzheimer's disease brain. J. Biol. Chem. 270:1995;7013-7016.
33. Kanai K., Matsubara E., Isoe K., Urakami K., Nakashima K., Arai H., Sasaki H., Abe K., Iwatsubo T., Kosaka T., Watanabe M., Tomidokoro Y., Shizuka M., Mizushima K., Nakamura T., Igeta Y., Ikeda Y., Amari M., Kawarabayashi T., Ishiguro K., Harigaya Y., Wakabayashi K., Okamoto K., Hirai S., Shoji M. Longitudinal study of cerebrospinal fluid levels of tau, Aβ1-40 and Aβ1-42(43) in Alzheimer's disease: A study in Japan. Ann. Neurol. 44:1998;17-26.
34. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T. D., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lahad E., Vitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., Younkin S. Secreted amyloid β protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2:1996;864-870.
35. Morishima-Kawashima M., Ihara Y. The presence of amyloid beta-protein in the detergent-insoluble membrane compartment of human neuroblastoma cells. Biochemistry. 37:1997;15247-15253.
36. Ginsberg S. D., Crino P. B., Hemby S. E., Weingarten J. A., Lee V. M.-Y., Eberwine J. H., Trojanowski J. Q. Predominance of neuronal mRNA's in individual Alzheimer's disease senile plaques. Ann. Neurol. 45:1999;174-181.